Coloplast CEO urged to take action: Release the billions!
Medtech firm Coloplast is on a buying spree, but its purchases are too few and far between, according to industry sources. Pharmaceutical firms Novo Nordisk and Lundbeck have led the way so far.
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN
The wealthy and highly lucrative medtech firm Coloplast needs to let go of some of its caution, release the billions and acquire either new firms or technology, according to several industry actors.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
